Address

Precise Investors

Friday, December 3, 2021
Latest News

Skin health company to develop and market its skin health technology

A skin health specialist, which raised £4.5m when it listed on the London stock market last week, will use the funds to drive forward its probiotic technology for skin health applications.

SkinBioTherapeutics, a University of Manchester spin-out, will focus on developing and commercialising its SkinBiotix technology platform.

The funds raised will enable it to focus on its development portfolio of three programmes – in skin care (sensitive skin), anti-infection and eczema.

Important:

The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.

Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.

There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.

Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.

Leave a Reply